Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Investments:
Fixed maturity available-for-sale securities, at fair value (amortized cost: 2019 – $92,192; 2018 – $92,429)	$ 103,659	$ 94,024
Trading securities	4,691	1,950
Equity securities	158	99
Mortgage loans on real estate	15,947	13,260
Policy loans	2,475	2,509
Derivative investments	2,201	1,107
Other investments	3,389	2,267
Total investments	132,520	115,216
Cash and invested cash	2,939	2,345
Deferred acquisition costs and value of business acquired	7,492	10,264
Premiums and fees receivable	440	570
Accrued investment income	1,182	1,119
Reinsurance recoverables	17,353	17,748
Funds withheld reinsurance assets	543	557
Goodwill	1,778	1,782
Other assets	15,939	15,713
Separate account assets	145,092	132,833
Total assets	325,278	298,147
Liabilities
Future contract benefits	36,108	34,648
Other contract holder funds	95,283	91,233
Short-term debt	300
Long-term debt	6,070	5,839
Reinsurance related embedded derivatives	339	3
Funds withheld reinsurance liabilities	1,817	1,740
Payables for collateral on investments	5,528	4,805
Other liabilities	14,742	12,696
Separate account liabilities	145,092	132,833
Total liabilities	305,279	283,797
Contingencies and Commitments (See Note 12)
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized
Common stock – 800,000,000 shares authorized; 198,327,250 and 205,862,760 shares issued and outstanding as of September 30, 2019, and December 31, 2018, respectively	5,192	5,392
Retained earnings	8,559	8,551
Accumulated other comprehensive income (loss)	6,248	407
Total stockholders' equity	19,999	14,350
Total liabilities and stockholders' equity	$ 325,278	$ 298,147